Rhumbline Advisers X Biotech Inc. Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
A detailed history of Rhumbline Advisers transactions in X Biotech Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 753 shares of XBIT stock, worth $4,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
753
Previous 753
-0.0%
Holding current value
$4,359
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding XBIT
# of Institutions
47Shares Held
3.96MCall Options Held
6.3KPut Options Held
1.7K-
Israel Englander Millennium Management LLC | New York, Ny927KShares$5.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA895KShares$5.18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY307KShares$1.78 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$1.44 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA195KShares$1.13 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $176M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...